| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |